Getinge AB (publ) (OTCMKTS:GNGBY) Short Interest Update

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 500 shares, an increase of 66.7% from the March 31st total of 300 shares. Based on an average daily volume of 12,400 shares, the days-to-cover ratio is currently 0.0 days.

Getinge AB (publ) Stock Up 1.9 %

Shares of GNGBY opened at $21.49 on Friday. Getinge AB has a 12-month low of $16.21 and a 12-month high of $25.35. The stock’s fifty day simple moving average is $20.03 and its 200-day simple moving average is $20.25.

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.29 EPS for the quarter. The business had revenue of $930.96 million during the quarter. Getinge AB (publ) had a return on equity of 7.69% and a net margin of 7.09%.

Getinge AB (publ) Increases Dividend

The firm also recently declared a dividend, which will be paid on Tuesday, May 14th. Shareholders of record on Wednesday, April 24th will be issued a $0.4164 dividend. This is an increase from Getinge AB (publ)’s previous dividend of $0.29. The ex-dividend date of this dividend is Tuesday, April 23rd. Getinge AB (publ)’s dividend payout ratio is 31.65%.

Getinge AB (publ) Company Profile

(Get Free Report)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.

Read More

Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.